Integra LifeSciences Holdings Corporation (IART) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Integra LifeSciences Holdings Corporation (IART) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Seeking Alpha • 20 hours ago

Integra LifeSciences to Present at the BofA Securities 2026 Health Care Conference

PRINCETON, N.J., May 08, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief financial officer Lea Knight will present at the BofA Securities 2026 Health Care Conference on May 12, 2026 at 4:20pm PT.

GlobeNewsWire • May 8, 2026

Integra (IART) Upgraded to Buy: What Does It Mean for the Stock?

Integra (IART) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Investment Research • May 7, 2026

Integra LifeSciences Holdings Corporation (IART) Q1 2026 Earnings Call Transcript

Integra LifeSciences Holdings Corporation (IART) Q1 2026 Earnings Call Transcript

Seeking Alpha • May 5, 2026

Integra LifeSciences Reports First Quarter 2026 Financial Results

PRINCETON, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today reported financial results for the first quarter ending March 31, 2026.

GlobeNewsWire • May 5, 2026

Integra (IART) Reports Q1 Earnings: What Key Metrics Have to Say

The headline numbers for Integra (IART) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks Investment Research • May 5, 2026

Integra LifeSciences (IART) Beats Q1 Earnings and Revenue Estimates

Integra LifeSciences (IART) came out with quarterly earnings of $0.54 per share, beating the Zacks Consensus Estimate of $0.41 per share. This compares to earnings of $0.41 per share a year ago.

Zacks Investment Research • May 5, 2026

Integra LifeSciences Announces Leadership Transition

Stuart Essig Appointed as Integra's Next President and Chief Executive Officer Michael McBreen Appointed Chief Commercial Officer

GlobeNewsWire • May 5, 2026

Is This the Right Time to Hold IART Stock in Your Portfolio?

Integra shows growth promise from strong CSS demand and global expansion, but debt load and macro pressures raise concerns for investors.

Zacks Investment Research • Apr 28, 2026

Integra LifeSciences (IART) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Integra (IART) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research • Apr 28, 2026